Moshe Dayan - Infimer Chief Executive Officer
| INFR Stock | ILA 60.40 0.00 0.00% |
CEO
Mr. Moshe Dayan was appointed Chief Executive Officer at Infimer Ltd effective June 3, 2018. His work experience includes the following roles Chief Executive Officer at Keter Plastic Ltd, Chief Executive Officer at IPG Israel Plastic Group of Keter Plastic and General Manager of the outdoor division at Keter Plastic . He holds a MBA degree from Bridgewater University. since 2018.
| Age | 59 |
| Tenure | 6 years |
| Professional Marks | MBA |
| Phone | 972 73 700 0266 |
| Web | http://www.infimer.com |
Infimer Management Efficiency
The company has return on total asset (ROA) of (0.3287) % which means that it has lost $0.3287 on every $100 spent on assets. This is way below average. Infimer's management efficiency ratios could be used to measure how well Infimer manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | CEO Age | ||
| Ari Pinto | Bank Hapoalim | 56 | |
| Robert Koremans | Teva Pharmaceutical Industries | 54 | |
| Ron Eilon | Bezeq Israeli Telecommunication | 52 | |
| Dov Kotler | Bank Hapoalim | 67 | |
| Carlo Notaristefani | Teva Pharmaceutical Industries | 60 | |
| Orit Lerer | Bank Hapoalim | 60 | |
| Ran Guron | Bezeq Israeli Telecommunication | 55 | |
| Zeev Morag | Bank Leumi Le Israel | 42 | |
| Orith Lerer | Bank Hapoalim | 59 | |
| Bezhalel Machlis | Elbit Systems | 60 | |
| Avraham Kochva | Bank Hapoalim | 54 | |
| David Mizrahi | Bezeq Israeli Telecommunication | 53 | |
| Daniel Tsiddon | Bank Leumi Le Israel | 59 | |
| Ron Fainaro | Bank Leumi Le Israel | 47 | |
| Zion Kenan | Bank Hapoalim | 59 | |
| Avner Mendelson | Bank Leumi Le Israel | 48 | |
| Ron Weksler | Bank Hapoalim | 44 | |
| Sigurdur Olafsson | Teva Pharmaceutical Industries | 46 | |
| Gil Sharon | Bezeq Israeli Telecommunication | 51 | |
| Rakefet RussakAminoach | Bank Leumi Le Israel | 51 | |
| Raanan Horowitz | Elbit Systems | N/A | |
Management Performance
| Return On Asset | -0.33 |
Infimer Leadership Team
Elected by the shareholders, the Infimer's board of directors comprises two types of representatives: Infimer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Infimer. The board's role is to monitor Infimer's management team and ensure that shareholders' interests are well served. Infimer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Infimer's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Moshe Dayan, Chief Executive Officer | ||
| Asaf Tennenbaum, External Director | ||
| Shirley Behar, External Director | ||
| Hadas Gelander, External Director | ||
| Batya Many, Vice President - Finance | ||
| Tal Tamir, Director | ||
| Hadasa Gelander, External Director | ||
| Oren Zahavi, Vice President - Business Development | ||
| Eyal Ayalon, Director | ||
| Gosta Tixell, Independent Director | ||
| Avshalom Shilin, Director | ||
| Yuval Tamir, Chairman of the Board, CEO | ||
| Eli Zahavi, Director | ||
| Eliahu Zahavi, Director |
Infimer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Infimer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.33 | |||
| Operating Margin | (9.80) % | |||
| Current Valuation | 25.15 M | |||
| Shares Outstanding | 1.06 M | |||
| Shares Owned By Insiders | 14.32 % | |||
| Shares Owned By Institutions | 10.35 % | |||
| Price To Earning | (867.76) X | |||
| Price To Sales | 4,759 X | |||
| Revenue | 378 K | |||
| Gross Profit | (899 K) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Infimer in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Infimer's short interest history, or implied volatility extrapolated from Infimer options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Infimer. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Infimer Stock analysis
When running Infimer's price analysis, check to measure Infimer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infimer is operating at the current time. Most of Infimer's value examination focuses on studying past and present price action to predict the probability of Infimer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infimer's price. Additionally, you may evaluate how the addition of Infimer to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |